Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CCR1 | P32246 | 2/20 | 0.44 |
| ▸ | CCR5 | P51681 | 2/20 | 0.44 |
| ▸ | CCR8 | P51685 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | ALPG | P10696 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SQOR | Q9Y6N5 | 3/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 4/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11992123 | 0.90 | LMNA (0.46) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992079 | 0.90 | SMN1; SMN2 (0.49) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992078 | 0.89 | SMN1; SMN2 (0.47) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992130 | 0.86 | KDM4E (0.42) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992074 | 0.85 | SMN1; SMN2 (0.46) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992133 | 0.85 | KDM4E (0.41) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992088 | 0.84 | SMN1; SMN2 (0.43) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992115 | 0.84 | SMN1; SMN2 (0.43) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992117 | 0.84 | KDM4E (0.43) | KDM4EHTTL3MBTL1LMNACCR1 | |
| SCHEMBL11992086 | 0.84 | LMNA (0.45) | KDM4EHTTL3MBTL1LMNACCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9273002-B2 | Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-03-01 | — | — | US | disclosed |
| US-9273002-B2 | Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-03-01 | — | — | US | disclosed |
| EP-2626346-A1 | BENZO[K]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20120211743-A1 | BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120211743-A1 | BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120211743-A1 | BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | KCNJ2, KCNE1, KCNK2 | KDM4E 764/4885HTT 1968/4885L3MBTL1 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.